Ibnsina Pharma Balance Sheet Health
Financial Health criteria checks 2/6
Ibnsina Pharma has a total shareholder equity of EGP1.4B and total debt of EGP12.4B, which brings its debt-to-equity ratio to 855.3%. Its total assets and total liabilities are EGP18.5B and EGP17.1B respectively. Ibnsina Pharma's EBIT is EGP1.1B making its interest coverage ratio 1.2. It has cash and short-term investments of EGP1.1B.
Key information
855.3%
Debt to equity ratio
ج.م12.39b
Debt
Interest coverage ratio | 1.2x |
Cash | ج.م1.13b |
Equity | ج.م1.45b |
Total liabilities | ج.م17.10b |
Total assets | ج.م18.55b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: ISPH's short term assets (EGP15.9B) exceed its short term liabilities (EGP15.9B).
Long Term Liabilities: ISPH's short term assets (EGP15.9B) exceed its long term liabilities (EGP1.2B).
Debt to Equity History and Analysis
Debt Level: ISPH's net debt to equity ratio (777.3%) is considered high.
Reducing Debt: ISPH's debt to equity ratio has increased from 473% to 855.3% over the past 5 years.
Debt Coverage: ISPH's debt is not well covered by operating cash flow (1%).
Interest Coverage: ISPH's interest payments on its debt are not well covered by EBIT (1.2x coverage).